Private Wealth Management Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03K Hold
106
– – ﹤0.01% 1325
2026
Q2
$1.24K Hold
106
– – ﹤0.01% 1263
2026
Q1
$1.78K Hold
106
– – ﹤0.01% 1116
2025
Q4
$1.7K Hold
106
– – ﹤0.01% 1136
2025
Q3
$1.31K Hold
106
– – ﹤0.01% 1216
2025
Q2
$1.22K Buy
106
+30
+39% +$356 ﹤0.01% 1212
2025
Q1
$1.14K Hold
76
– – ﹤0.01% 1226
2024
Q4
$1.32K Hold
76
– – ﹤0.01% 1223
2024
Q3
$1.41K Hold
76
– – ﹤0.01% 1191
2024
Q2
$1.54K Hold
76
– – ﹤0.01% 1147
2024
Q1
$1.3K Buy
+76
New +$1.2K ﹤0.01% 1157

Other funds holding CLB

Private Wealth Management Group's CLB Position: Q3 2026 in Review

Private Wealth Management Group held its Core Laboratories (CLB) position steady in Q3 2026 at 106 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Private Wealth Management Group first reported a position in CLB in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.78K in Q1 2026. 24 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Private Wealth Management Group held 106 shares of Core Laboratories worth $1.03K as of Q3 2026.
  • Private Wealth Management Group left its Core Laboratories share count unchanged in Q3 2026.
  • Core Laboratories made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #1325 holding.
  • Private Wealth Management Group first reported a position in Core Laboratories in Q1 2024 and has held it in 11 quarters since.
  • Private Wealth Management Group's Core Laboratories position peaked at $1.78K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.